Work

External validation of a clinical risk score for the presence of cardiovascular autonomic neuropathy in type 1 diabetes

Year: 2025
Type: article
Study design: Observational Study
Abstract: AIMS: To validate in an independent external population a CAN Risk Score previously developed in type 1 diabetes (T1D) and validated for cardiovascular autonomic neuropathy (CAN) with a good diagnostic accuracy. METHODS: Forty-seven participants with T1D (age 47.7 ± 13.2 years, duration of diabetes 30.0 (19.0-40.5) years, 24 males) underwent 4 cardiovascular reflex tests (CARTs) to diagnose early and confirmed CAN (according to 1 or 2 abnormal results). CAN Risk Score was calculated from resting heart rate, HbA1c, retinopathy and/or nephropathy, cardiovascular disease, HDL cholesterol, systolic blood pressure and smoking (range 0-10). RESULTS: Eleven participants (23.4 %) had CAN. The CAN Risk Score was higher in subjects with overall CAN (early and confirmed) (P = 0.0498) and with confirmed CAN (P = 0.0142) compared to those without, and correlated with CARTs severity (rho = 0.32, P = 0.026), Expiration/Inspiration ratio (r = -0.33, P = 0.0258) and Valsalva ratio (r = -0.47, P = 0.0015). A CAN Risk Score ≥ 4 was found in 19 participants and was associated with the presence of confirmed CAN (P = 0.0129). The CAN Risk Score showed an area under the ROC curve (AUC) of 0.802 ± 0.080 for confirmed CAN, and at the cut-off of 4, sensitivity, specificity and negative predictive values of 85.71 %, 67.50 % and 96.43 %. CONCLUSIONS: This study confirmed the diagnostic value of the CAN Risk Score and supports its inclusion in a diagnostic algorithm to identify candidates for CARTs, thereby reducing universal screening. Using routinely available clinical data as categorical variables, the score is easy to calculate and implement in clinical settings.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,760
OpenAlex ID: W4410080241
FWCI: 0.603
Cites: 23
Cited by: 1
Related to: 10